N-butyl-N,2-diethyl-8-mesityl-7-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine-3-carboxamide

ID: ALA1077155

PubChem CID: 46881396

Max Phase: Preclinical

Molecular Formula: C24H34N4O2

Molecular Weight: 410.56

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCCN(CC)C(=O)c1c(CC)nc2n1CCC(=O)N2c1c(C)cc(C)cc1C

Standard InChI:  InChI=1S/C24H34N4O2/c1-7-10-12-26(9-3)23(30)22-19(8-2)25-24-27(22)13-11-20(29)28(24)21-17(5)14-16(4)15-18(21)6/h14-15H,7-13H2,1-6H3

Standard InChI Key:  ANNYOXHYWHWCPU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -0.6796   -8.4583    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0324   -8.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0324   -7.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6796   -6.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1760   -8.3082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3917   -8.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3960   -7.2236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1841   -6.9738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6639   -7.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4028   -6.1784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8232   -5.5912    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1724   -5.8815    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7462   -8.4635    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6796   -9.2833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3962   -9.6944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3966  -10.5186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6815  -10.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0353  -10.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0321   -9.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7453   -9.2775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1100   -9.2807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6804  -11.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1771   -5.0573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8934   -4.6480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5815   -6.5973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4065   -6.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4889   -7.6529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9070   -6.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8159   -7.3171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6409   -7.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
 14 15  2  0
  2  3  1  0
 15 16  1  0
  5  6  2  0
 16 17  2  0
  7  8  1  0
 17 18  1  0
  8  9  2  0
 18 19  2  0
 19 14  1  0
  9  5  1  0
 19 20  1  0
  3  4  1  0
 15 21  1  0
  8 10  1  0
 17 22  1  0
  6  7  1  0
 12 23  1  0
 10 11  2  0
 23 24  1  0
 12 25  1  0
 10 12  1  0
 25 26  1  0
  7  4  1  0
  9 27  1  0
  2 13  2  0
 27 28  1  0
  6  1  1  0
 26 29  1  0
  1 14  1  0
 29 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1077155

   N-butyl-N,2-diethyl-8-mesityl-7-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 410.56

Molecular Weight (Monoisotopic): 410.2682

AlogP: 4.70

#Rotatable Bonds: 7

Polar Surface Area: 58.44

Molecular Species: NEUTRAL

HBA: 4

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 1.20

CX LogP: 4.73

CX LogD: 4.73

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.66

Np Likeness Score: -1.15

References

1. Vrudhula VM, Dasgupta B, Pin SS, Burris KD, Balanda LA, Fung LK, Fiedler T, Browman KE, Taber MT, Zhang J, Macor JE, Dubowchik GM..  (2010)  Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of corticotropin-releasing factor type 1 receptor (CRF1R).,  20  (6): [PMID:20185312] [10.1016/j.bmcl.2010.01.127]

Source

Source(1):

• Scientific Literature